Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
6.90% | 4 M | 65.62% | 3.18% | 2050-07-09 | 2 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.78% | 430 K | 64.54% | 3.38% | 2060-07-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.50% | 9.54 M | 73.27% | 3.03% | 2040-07-09 | 1.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 6.08% | 4 K | 92.46% | 5.25% | 2045-06-23 | 500.41 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
5.99% | 10.6 M | 97.73% | 5.80% | 2064-07-05 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.84% | 4.6 M | 97.89% | 5.65% | 2054-07-05 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.73% | 2.08 M | 99.28% | 5.65% | 2044-07-05 | 800 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.33% | 2.35 M | 99.82% | 5.30% | 2034-07-05 | 1.1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.32% | 2.83 M | 86.87% | 2.05% | 2030-03-31 | 2.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4.83% | 1.78 M | 99.72% | 4.00% | 2025-06-23 | 800.17 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
4.82% | 465 K | 100.59% | 5.00% | 2028-11-26 | 1.73 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4.74% | 0 | 97.72% | 3.20% | 2026-09-23 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Shire Acquisitions Investments Ireland DAC |
4.27% | 0 | 78.89% | 2.00% | 2040-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.45% | 0 | 87.78% | 1.38% | 2032-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.16% | 0 | 99.22% | 3.00% | 2030-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.06% | 0 | 92.03% | 1.00% | 2029-07-09 | 850 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.87% | 0 | 95.26% | 0.75% | 2027-07-09 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.78% | 0 | 99.11% | 2.25% | 2026-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.71% | 0 | 116.57% | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4.00% | 2025-06-23 | 303 K USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
— | — | — | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. |